candesartan has been researched along with ramipril in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 15 (46.88) | 29.6817 |
| 2010's | 15 (46.88) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dipette, DJ; Li, J; Supowit, SC; Wang, DH; Zhao, H | 1 |
| Behrends, M; Gres, P; Heusch, G; Post, H; Schulz, R; Weidenbach, R | 1 |
| Büttner, C; Dendorfer, A; Kurz, T; Richardt, D; Richardt, G; Schäfer, U; Wolfrum, S | 1 |
| Hong, SB; Kim, ES; Kim, KA; Kim, MJ; Lee, SW; Song, JH; Suh, JH | 1 |
| Critchley, J; Critchley, L; Ding, B; Fok, B; James, A; Thomas, GN; Tomlinson, B; Wang, D | 1 |
| Addicks, K; Beirowski, B; Bloch, W; Gross, O; Koepke, ML; Schulze-Lohoff, E; Smyth, N; Weber, M | 1 |
| Williams, B | 1 |
| Cohen-Solal, A; Dietz, R; Eichhorn, E; Erhardt, L; Hobbs, FD; Krum, H; Maggioni, A; McKelvie, RS; McMurray, J; Piña, IL; Soler-Soler, J; Swedberg, K | 1 |
| Cha, SH; Kim, MJ; Lee, HJ; Lee, SW; Park, GH; Song, JH | 1 |
| Ahn, YB; Cha, BY; Hong, OK; Jeong, IK; Kim, JW; Kim, MJ; Ko, SH; Son, HY; Song, KH; Yoon, KH | 1 |
| Dendorfer, A; Dodt, C; Dominiak, P; Jöhren, O; Pahlke, F; Raasch, W; Voges, I; Wittmershaus, C | 1 |
| Cox, CD; Meyerrose, GE; Peek, MC; Seifert, CF; Simoni, JS; Tsikouris, JP | 1 |
| Ahn, JY; Chung, WJ; Han, SH; Kim, JA; Koh, KK; Lee, Y; Quon, MJ; Shin, EK | 1 |
| Gianni, M; Grandi, AM; Guasti, L; Laurita, E; Marchesi, C; Maresca, AM; Nicolini, E; Solbiati, F; Venco, A | 1 |
| Krikov, M; Müller, S; Thone-Reineke, C; Unger, T; Villringer, A | 1 |
| Han, SH; Kim, SJ; Koh, KK; Koh, Y; Lee, Y; Quon, MJ; Shin, EK | 1 |
| Amann, K; Frank, H; Freiberger, V; Heemann, U | 1 |
| Neldam, S | 1 |
| Adawi, S; Asmer, I; Flugelman, MY; Shiran, A | 1 |
| Angeloni, E; Benedetto, U; di Bartolomeo, R; Melina, G; Refice, S; Roscitano, A; Sinatra, R | 1 |
| Mitsuyama, S | 1 |
| Balaguer, JM; Billings, FT; Brown, NJ; Byrne, JG; C, Y; Petracek, MR; Pretorius, M; Wright, P | 1 |
| Akpek, M; Kaya, EG; Kaya, MG; Lam, YY; Sarli, B; Topsakal, R | 1 |
| Azizi, M; Blanchard, A; Charbit, B; Ezan, E; Funck-Brentano, C; Ménard, J; Peyrard, S; Wuerzner, G | 1 |
| Farinde, A | 1 |
| Flegal, JM; Mote, PL; Spindler, SR | 1 |
| Bessaguet, F; Danigo, A; Demiot, C; Desmoulière, A; Magy, L; Sturtz, F | 1 |
| Bramlage, P; Schmidt, S; Sims, H | 1 |
| Davydenko, I; Maruschak, A; Shorikov, E; Slobodyan, K; Timofiichuk, I | 1 |
| Bachmann, HS; Besser, M; Severing, AL; Stuermer, EK; Terberger, N | 1 |
| Kovpak, A; Tsubanova, N; Zamorskyi, I | 1 |
3 review(s) available for candesartan and ramipril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Protection against stroke and dementia: an update on the latest clinical trial evidence.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Clinical Trials as Topic; Cognition; Dementia; Hydrochlorothiazide; Ramipril; Stroke; Tetrazoles; Verapamil | 2004 |
Choosing an angiotensin-receptor blocker: blood pressure lowering, cardiovascular protection or both?
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Humans; Hypertension; Losartan; Ramipril; Risk Factors; Telmisartan; Tetrazoles | 2010 |
10 trial(s) available for candesartan and ramipril
| Article | Year |
|---|---|
The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Cross-Over Studies; Diabetic Nephropathies; Female; Glomerulonephritis, IGA; Humans; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta | 2003 |
Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biomarkers; Biphenyl Compounds; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Ramipril; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Treatment Outcome | 2006 |
Lack of effect on coronary atherosclerotic disease biomarkers with modest dosing of an angiotensin-converting enzyme inhibitor, angiotensin II type-1 receptor blocker, and the combination.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biomarkers; Biphenyl Compounds; Coronary Artery Disease; Cross-Over Studies; Drug Therapy, Combination; Endothelium, Vascular; Female; Fibrinolysis; Humans; Inflammation; Male; Middle Aged; Ramipril; Tetrazoles | 2006 |
Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients.
Topics: Adiponectin; Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Tetrazoles; Treatment Outcome | 2007 |
Effects of dual blockade of Renin-Angiotensin system on concentric left ventricular hypertrophy in essential hypertension: a randomized, controlled pilot study.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Pilot Projects; Ramipril; Renin-Angiotensin System; Tetrazoles; Treatment Outcome | 2008 |
Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.
Topics: Adipokines; Adiponectin; Adult; Aged; Amlodipine; Antihypertensive Agents; Atenolol; Benzimidazoles; Biphenyl Compounds; Cholesterol, HDL; Comorbidity; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Single-Blind Method; Tetrazoles; Triglycerides | 2010 |
Dual renin-angiotensin system blockade for patients with prosthesis-patient mismatch.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aortic Valve Stenosis; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Female; Follow-Up Studies; Heart Valve Prosthesis; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Male; Metoprolol; Prosthesis Design; Prosthesis Failure; Ramipril; Renin-Angiotensin System; Retrospective Studies; Tetrazoles; Treatment Outcome | 2010 |
Comparative effects of angiotensin receptor blockade and ACE inhibition on the fibrinolytic and inflammatory responses to cardiopulmonary bypass.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Blood Transfusion; Bradykinin; Cardiopulmonary Bypass; Endpoint Determination; Female; Fibrinolysis; Hematocrit; Hospital Mortality; Humans; Inflammation; Interleukins; Length of Stay; Male; Middle Aged; Monitoring, Intraoperative; Perioperative Care; Postoperative Complications; Ramipril; Tetrazoles; Treatment Outcome | 2012 |
Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Drug Therapy, Combination; Echocardiography; Female; Furosemide; Heart Function Tests; Hong Kong; Humans; Male; Predictive Value of Tests; Prognosis; Propanolamines; Ramipril; Spironolactone; Survival Rate; Tenascin; Tetrazoles; Turkey; Ventricular Remodeling | 2013 |
Effect of contrasted sodium diets on the pharmacokinetics and pharmacodynamic effects of renin-angiotensin system blockers.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Chromatography, Liquid; Cross-Over Studies; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Electrocardiography; Humans; Immunoradiometric Assay; Male; Ramipril; Reference Values; Renin; Renin-Angiotensin System; Sodium, Dietary; Tetrazoles; Treatment Outcome; Young Adult | 2013 |
19 other study(ies) available for candesartan and ramipril
| Article | Year |
|---|---|
Reciprocal role of the AT1 receptor in modulating renal and neuronal AT1 mRNA expression.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcitonin Gene-Related Peptide; Hypertension; Kidney; Male; Neurons, Afferent; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Tetrazoles | 1999 |
Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Hemodynamics; Myocardial Infarction; Ramipril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Swine; Tetrazoles | 2000 |
Effect of ACE-inhibitor ramiprilat and AT1-receptor antagonist candesartan on cardiac norepinephrine release: comparison between ischemic and nonischemic conditions.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Male; Myocardial Ischemia; Myocardium; Norepinephrine; Ramipril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Tetrazoles | 2002 |
The effects of candesartan and ramipril on adrenal catecholamine release in anaesthetized dogs.
Topics: Adrenal Glands; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Catecholamines; Chromatography, High Pressure Liquid; Denervation; Dogs; Electric Stimulation; Homeostasis; Male; Ramipril; Stimulation, Chemical; Tetrazoles | 2004 |
Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Disease Models, Animal; Fibrosis; Hypertension, Renal; Kidney; Mice; Ramipril; Tetrazoles; Time Factors | 2004 |
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzopyrans; Biphenyl Compounds; Bisoprolol; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Ethanolamines; Evidence-Based Medicine; Guideline Adherence; Heart Failure; Humans; Indoles; Lisinopril; Metoprolol; Mineralocorticoid Receptor Antagonists; Nebivolol; Practice Guidelines as Topic; Propanolamines; Ramipril; Spironolactone; Stroke Volume; Tetrazoles; Valine; Valsartan | 2005 |
High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Connective Tissue Growth Factor; Dose-Response Relationship, Drug; Extracellular Matrix; Extracellular Matrix Proteins; Fibronectins; Fibrosis; Glucose; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Male; Pancreas; Pancreatitis; Ramipril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta | 2006 |
Angiotensin II inhibition reduces stress sensitivity of hypothalamo-pituitary-adrenal axis in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Corticosterone; Gene Expression Regulation; Hypothalamus; Male; Mibefradil; Pituitary-Adrenal System; Ramipril; Rats; Rats, Inbred SHR; Tetrazoles | 2006 |
Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Brain Ischemia; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Incidence; Male; Pilot Projects; Ramipril; Rats; Rats, Wistar; Receptor, trkB; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Stroke; Tetrazoles | 2008 |
Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
Topics: Adult; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Female; Fumarates; Glomerulosclerosis, Focal Segmental; Humans; Hypertension, Renal; Kidney Transplantation; Nephrotic Syndrome; Plasma Exchange; Proteinuria; Ramipril; Recurrence; Renin; Renin-Angiotensin System; Rituximab; Tetrazoles | 2009 |
Spontaneous resolution of severe mitral regurgitation in a patient with a flail mitral valve.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Echocardiography; Echocardiography, Doppler, Color; Follow-Up Studies; Hemodynamics; Humans; Male; Mitral Valve; Mitral Valve Insufficiency; Mitral Valve Prolapse; Ramipril; Remission, Spontaneous; Tetrazoles; Ventricular Remodeling | 2010 |
[Prevention of hypertension by drugs and immunization against angiotensin II].
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Female; Humans; Hypertension; Male; Middle Aged; Ramipril; Tetrazoles; Vaccines | 2011 |
Drugs for treating hypertension.
Topics: Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Drugs, Generic; Humans; Hydrochlorothiazide; Hypertension; Nifedipine; Prescription Drugs; Ramipril; Tetrazoles | 2013 |
Combined statin and angiotensin-converting enzyme (ACE) inhibitor treatment increases the lifespan of long-lived F1 male mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Glucose; Cholesterol; Chromatography, Liquid; Cohort Studies; Drug Synergism; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Longevity; Male; Mice; Mice, Inbred C57BL; Ramipril; Simvastatin; Tandem Mass Spectrometry; Tetrazoles; Triglycerides | 2016 |
Candesartan prevents resiniferatoxin-induced sensory small-fiber neuropathy in mice by promoting angiotensin II-mediated AT2 receptor stimulation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Calcitonin Gene-Related Peptide; Diterpenes; Ganglia, Spinal; Imidazoles; Male; Mice; Mice, Knockout; Neuroprotective Agents; Pyridines; Ramipril; Receptor, Angiotensin, Type 2; Sensory Receptor Cells; Small Fiber Neuropathy; Substance P; Tetrazoles | 2017 |
Fixed-dose vs free-dose combinations for the management of hypertension-An analysis of 81 958 patients.
Topics: Age Factors; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Comorbidity; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged; Patient Compliance; Ramipril; Tetrazoles | 2018 |
PATHOMORPHOLOGY OF THE MYOCARDIUM, KIDNEY AND LIVER IN SPONTANEOUSLY HYPERTENSIVE RATS TREATED WITH SHORT AND LONG-TERM USE RAMIPRIL AND CANDESARTAN.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Hypertension; Kidney; Liver; Myocardium; Ramipril; Rats, Inbred SHR; Tetrazoles; Time Factors | 2018 |
Side Effects of Frequently Used Antihypertensive Drugs on Wound Healing in vitro.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Cell Line; Cell Movement; Diuretics; Fibroblasts; Humans; Hydrochlorothiazide; Keratinocytes; Metoprolol; Ramipril; Tetrazoles; Wound Healing | 2019 |
Study of possible sex features of ramipril and candesartan treatment under experimental arterial hypertension in rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Female; Hypertension; Male; Ramipril; Rats; Tetrazoles | 2022 |